Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib
- 15 April 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (8), 2270-2272
- https://doi.org/10.1016/j.bmcl.2009.02.090
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Metabolism and excretion of imrecoxib in ratXenobiotica, 2006
- Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes1Acta Pharmacologica Sinica, 2006
- Selective cyclooxygenase 2 inhibitors and cardiovascular eventsArthritis & Rheumatism, 2005
- Adverse Cardiovascular Effects of the CoxibsJournal of Medicinal Chemistry, 2005
- The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitorBioorganic & Medicinal Chemistry Letters, 1999
- Recently reported inhibitors of cyclooxygenase-2Expert Opinion on Therapeutic Patents, 1998
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Prostaglandin Endoperoxide H Synthases-1 and -2Advances in Immunology, 1996
- Synthesis of α-Helices Having a Positively Charged Random Coil-Block on Either N- or C-TerminalBulletin of the Chemical Society of Japan, 1988
- Detection and Isolation of an Endoperoxide Intermediate in Prostaglandin BiosynthesisProceedings of the National Academy of Sciences of the United States of America, 1973